AMUBARVIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 17:28:56 GMT 2023` Edited by `admin` on `Sat Dec 16 17:28:56 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	2AD5KH3SE4
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

AMUBARVIMAB

Official Name

English

BRII 196 [WHO-DD]

Common Name

English

BRII196

Code

English

amubarvimab [INN]

Common Name

English

AMUBARVIMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY

Common Name

English

BRII-196

Code

English

IMMUNOGLOBULIN G1-KAPPA,ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV) (SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN)); HOMO SAPIENS MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN HOMO SAPIENS (1-447) (VH(HOMO SAPIENS (IGHV3-66*01 (96%)-(IGHD)-IGHJ6*01

Common Name

English

Code System Code Type Description

USAN

JK-255

Created by admin on Sat Dec 16 17:28:56 GMT 2023 , Edited by admin on Sat Dec 16 17:28:56 GMT 2023

PRIMARY

INN

11988

Created by admin on Sat Dec 16 17:28:56 GMT 2023 , Edited by admin on Sat Dec 16 17:28:56 GMT 2023

PRIMARY

NCI_THESAURUS

C175227

Created by admin on Sat Dec 16 17:28:56 GMT 2023 , Edited by admin on Sat Dec 16 17:28:56 GMT 2023

PRIMARY

FDA UNII

2AD5KH3SE4

Created by admin on Sat Dec 16 17:28:56 GMT 2023 , Edited by admin on Sat Dec 16 17:28:56 GMT 2023

PRIMARY

SMS_ID

300000026354

Created by admin on Sat Dec 16 17:28:56 GMT 2023 , Edited by admin on Sat Dec 16 17:28:56 GMT 2023

PRIMARY

CAS

2509447-07-6

Created by admin on Sat Dec 16 17:28:56 GMT 2023 , Edited by admin on Sat Dec 16 17:28:56 GMT 2023

PRIMARY

From	To
1_22	1_95
2_22	2_95
2_144	2_200
2_220	4_214
2_261	2_321
1_144	1_200
2_367	2_425
3_23	3_89
3_134	3_194
4_23	4_89
4_134	4_194
1_220	3_214
1_226	2_226
1_229	2_229
1_261	1_321
1_367	1_425

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_297
N	2_297

Related Record Type Details


					8R39BE7TJJ

SPIKE GLYCOPROTEIN (SARS-COV-2)

TARGET -> INHIBITOR

Interaction Type:

BINDING

Amount:


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->INHIBITOR

Amount:

Related Record Type Details


					2AD5KH3SE4

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL